Global Leaders in Dementia Meet to Stop Alzheimer's by 2025 LAUSANNE, Switzerland, Dec. 17, 2015 (GLOBE NEWSWIRE) -- On December 15-16, experts convened in Lausanne to define an action plan to speed effective treatments and diagnostics for Alzheimer's disease...

Axovant Sciences Joins the Global CEO Initiative on Alzheimer's Disease WASHINGTON, Oct. 13, 2015 (GLOBE NEWSWIRE) -- The Global CEO Initiative on Alzheimer's Disease (CEOi) today announced that Axovant Sciences will join the CEOi as part of its ongoing effort to advance...

GAP and IMI to Sign MOU to Accelerate Alzheimer's Drug Development WASHINGTON and NICE, FRANCE, March 19, 2015 (GLOBE NEWSWIRE) -- The Global Alzheimer's Platform (GAP) and the Innovative Medicines Initiative (IMI) announced today that they will sign a Memorandum of...

Global CEO Initiative on Alzheimer's Disease (CEOi) Launches Program to Harness Power of Big Data, Accelerating Pace of Alzheimer's Research WASHINGTON, Feb. 25, 2015 (GLOBE NEWSWIRE) -- The Global CEO Initiative on Alzheimer's Disease (CEOi) has developed an innovative research initiative with the potential to bring new evidence and...